New study aims to help men with prostate cancer skip unnecessary treatment

NCT ID NCT05424783

NEW Recruiting now Knowledge-focused Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

First seen Apr 28, 2026 · Last updated Apr 28, 2026

Summary

This study enrolls 222 men with low-risk prostate cancer to see if using MRI and a genetic test (Genomic Prostate Score) helps them stick with active surveillance (monitoring instead of immediate treatment). Researchers will compare how well these men follow monitoring schedules versus those in an earlier study who had fewer or no tests. The goal is to find the right balance of testing to catch dangerous tumors early while avoiding unnecessary biopsies and treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Northwestern University
ACTIVE_NOT_RECRUITING

Chicago, Illinois, 60611, United States
University of Illinois at Chicago
RECRUITING

Chicago, Illinois, 60612, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER